Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Abbott Hits a Triple
Motley Fool
Saturday, May 21, 2011 - 11:08am
tags:
Abbott Laboratories, TriLipix, cholesterol
J&J Puerto Rico Plant Has ‘Deeply Troubling’ Lack of Oversight
Bloomberg
Saturday, May 21, 2011 - 11:07am
tags:
JNJ
The Big Winner of the EU Drug Approval Bonanza
Motley Fool
Saturday, May 21, 2011 - 11:05am
tags:
Benlysta, Human Genome Sciences, Vibativ, Theravance, GSK, Victrelis, Merck, Xgeva, Amgen, Yervoy, Bristol-Myers Squibb, Fampyra, Acorda Therapeutics, Biogen Idec
Amgen Announces Voting Results Of Annual Meeting of Stockholders
Yahoo/PR NewsWire
Saturday, May 21, 2011 - 11:01am
tags:
Amgen
Targacept prices public offering for 3.7M shares
Yahoo/AP
Saturday, May 21, 2011 - 11:01am
tags:
Targacept, IPOs
Risk-Reward Balanced at Allos
Yahoo/Zacks
Saturday, May 21, 2011 - 11:00am
tags:
Allos
Codexis Becomes Target for Suitors Seeking Enzymes, Chief Executive Says
Bloomberg
Saturday, May 21, 2011 - 10:46am
tags:
Codexis, enzymes
BioSpecifics Technologies Corp. Provides Update on XIAPEX® Launch Progress in EU
Yahoo/PR NewsWire
Saturday, May 21, 2011 - 10:45am
tags:
BioSpecifics Technologies, Xiapex, Dupuytren's Contracture
Diet-drug makers move into spotlight
MarketWatch
Saturday, May 21, 2011 - 10:44am
tags:
Arena Pharmaceuticals, Vivus, Albany Molecular Research
Cephalon Granted Temporary Restraining Order in Amrix Patent Litigation
Yahoo/PR NewsWire
Saturday, May 21, 2011 - 10:42am
tags:
Cephalon, Amrix, Mylan
Cell Therapeutics-FDA set early June pixantrone meeting
bizjournals.com
Saturday, May 21, 2011 - 10:41am
tags:
Cell Therapeutics, pixantrone, PIX301, cancer
Merck Serious About Growth
Seeking Alpha
Friday, May 20, 2011 - 5:04pm
tags:
Merck
[video] Cancer Conference Lures Pharma Companies
CNBC
Friday, May 20, 2011 - 12:21pm
tags:
ASCO, cancer
CytRx Corp. Stock Review: Primed for Growth
Seeking Alpha
Friday, May 20, 2011 - 12:19pm
tags:
CytRx, Amgen
Merck Sales Rep Is Fired For Sleepdriving
Pharmalot
Friday, May 20, 2011 - 12:18pm
tags:
Merck, Gardasil, firings, drug reps
FDA approves new HIV drug from Johnson & Johnson
Yahoo/AP
Friday, May 20, 2011 - 12:15pm
tags:
HIV, FDA, JNJ, Edurant
Immunogen aims for $84M stock offering
Bizjournals.com
Friday, May 20, 2011 - 12:14pm
tags:
Immunogen, stock offering
Pfizer pays Auxilium $7.5M for first German sale of Xiapex
Bizjournals.com
Friday, May 20, 2011 - 12:13pm
tags:
Pfizer, Xiapex, Auxilium
FDA Sets Meeting Date in Early June to Discuss Re-submission of Pixantrone NDA for Accelerated Approval
Yahoo
Friday, May 20, 2011 - 9:47am
tags:
FDA, pixantrone, Cell Therapeutics, non-Hodgkin's lymphoma
Takeda Pays ‘Upper Limit’ for Nycomed as Competition Looms
Bloomberg
Friday, May 20, 2011 - 9:45am
tags:
M&A, Takeda, Nycomed, diabetes, Actos

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.